(Re)insurers will be 'pulled in' to opioid crisis
(Re)insurers will inevitably be drawn in to impending litigation from the ongoing opioid epidemic in the US, according to the CEO of the blue-chip specialty insurance group, WR Berkley.
(Re)insurers will inevitably be drawn in to impending litigation from the ongoing opioid epidemic in the US, according to the CEO of the blue-chip specialty insurance group, WR Berkley.